Barnes E A, Murray B R, Robinson D M, Underwood L J, Hanson J, Roa W H
Department of Radiation Oncology, Cross Cancer Institute, Alberta, Edmonton, Canada.
Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):1091-8. doi: 10.1016/s0360-3016(01)01592-9.
To examine the dosimetric benefit of self-gated radiotherapy at deep-inspiration breath hold (DIBH) in the treatment of patients with non-small-cell lung cancer (NSCLC). The relative contributions of tumor immobilization at breath hold (BH) and increased lung volume at deep inspiration (DI) in sparing high-dose lung irradiation (> or = 20 Gy) were examined.
Ten consecutive patients undergoing radiotherapy for Stage I-IIIB NSCLC who met the screening criteria were entered on this study. Patients were instructed to BH at DI without the use of external monitors or breath-holding devices (self-gating). Computed tomography (CT) scans of the thorax were performed during free breathing (FB) and DIBH. Fluoroscopy screened for reproducible tumor position throughout DIBH, and determined the maximum superior-inferior (SI) tumor motion during both FB and DIBH. Margins used to define the planning target volume (PTV) from the clinical target volume included 1 cm for setup error and organ motion, plus an additional SI margin for tumor motion, as determined from fluoroscopy. Three conformal treatment plans were then generated for each patient, one from the FB scan with FB PTV margins, a second from the DIBH scan with FB PTV margins, and a third from the DIBH scan with DIBH PTV margins. The percent of total lung volume receiving > or = 20 Gy (using a prescription dose of 70.9 Gy to isocenter) was determined for each plan.
Self-gating at DIBH was possible for 8 of the 10 patients; 2 patients were excluded, because they were not able to perform a reproducible DIBH. For these 8 patients, the median BH time was 23 (range, 19-52) s. The mean percent of total lung volume receiving > or = 20 Gy under FB conditions (FB scan with FB PTV margins) was 12.8%. With increased lung volume alone (DIBH scan with FB PTV margins), this was reduced to 11.0%, tending toward a significant decrease in lung irradiation over FB (p = 0.086). With both increased lung volume and tumor immobilization (DIBH scan with DIBH PTV margins), the mean percent lung volume receiving > or = 20 Gy was further reduced to 8.8%, a significant decrease in lung irradiation compared to FB (p = 0.011). Furthermore, at DIBH, the additional benefit provided by tumor immobilization (i.e., using DIBH instead of FB PTV margins) was also significant (p = 0.006). The relative contributions of tumor immobilization and increased lung volume toward reducing the percent total lung volume receiving > or = 20 Gy were patient specific; however, all 8 of the patients analyzed showed a dosimetric benefit with this DIBH technique.
Compared to FB conditions, at DIBH the mean reduction in percent lung volume receiving > or = 20 Gy was 14.3% with the increase in lung volume alone, 22.1% with tumor immobilization alone, and 32.5% with the combined effect. The dosimetric benefit seen at DIBH was patient specific, and due to both the increased lung volume seen at DI and the PTV margin reduction seen with tumor immobilization.
研究在非小细胞肺癌(NSCLC)患者治疗中,深吸气屏气(DIBH)时自门控放疗的剂量学益处。研究了屏气(BH)时肿瘤固定和深吸气(DI)时肺容积增加在减少高剂量肺照射(≥20 Gy)方面的相对贡献。
10例连续接受I - IIIB期NSCLC放疗且符合筛选标准的患者纳入本研究。指导患者在深吸气时屏气,不使用外部监测器或屏气装置(自门控)。在自由呼吸(FB)和DIBH期间进行胸部计算机断层扫描(CT)。通过荧光透视在整个DIBH过程中筛选可重复的肿瘤位置,并确定FB和DIBH期间肿瘤上下方向(SI)的最大移动。用于从临床靶体积定义计划靶体积(PTV)的边界包括1 cm的摆位误差和器官运动边界,再加上荧光透视确定的肿瘤运动的额外SI边界。然后为每位患者生成三个适形治疗计划,一个来自带有FB PTV边界的FB扫描,第二个来自带有FB PTV边界的DIBH扫描,第三个来自带有DIBH PTV边界的DIBH扫描。确定每个计划中接受≥20 Gy(等中心处方剂量为70.9 Gy)的全肺体积百分比。
10例患者中有8例能够在DIBH时进行自门控;2例患者被排除,因为他们无法进行可重复的DIBH。对于这8例患者,中位屏气时间为23(范围19 - 52)秒。在FB条件下(带有FB PTV边界的FB扫描),接受≥20 Gy的全肺体积平均百分比为12.8%。仅肺容积增加时(带有FB PTV边界的DIBH扫描),该百分比降至11.0%,与FB相比肺照射有显著降低趋势(p = 0.086)。肺容积增加且肿瘤固定时(带有DIBH PTV边界的DIBH扫描),接受≥20 Gy的肺体积平均百分比进一步降至8.8%,与FB相比肺照射显著降低(p = 0.011)。此外,在DIBH时,肿瘤固定带来的额外益处(即使用DIBH而非FB PTV边界)也很显著(p = 0.006)。肿瘤固定和肺容积增加对减少接受≥20 Gy的全肺体积百分比的相对贡献因患者而异;然而,所有8例分析的患者均显示该DIBH技术具有剂量学益处。
与FB条件相比,在DIBH时,仅肺容积增加使接受≥20 Gy的肺体积百分比平均降低14.3%,仅肿瘤固定时降低22.1%,两者联合作用时降低32.5%。DIBH时所见的剂量学益处因患者而异,是由于DI时肺容积增加以及肿瘤固定时PTV边界减小所致。